Blog
Another Angle: Jaroslav Menčík from Ambit on AI Regulations in Healthtech
The European intersection of the AI Act, MDR/IVDR, GDPR and the Digital Omnibus today resembles a minefield. For healthtech startups and investors, however, it is not just about the threat of sanctions – it is about company value.
In the first edition of our series Another Angle, we bring insights from those closest to the field.
Jaroslav Menčík, Partner and Head of the Technology Team at Ambit, reveals what investors should really look for in healthtech due diligence, why a wrong MDR or IVDR classification can derail growth, and how the Digital Omnibus is changing valuation and regulatory risk assessment. As compliance turns into a barrier to entry, those who get it right gain a decisive edge. Read the full interview and see regulation from another angle.